ArticleScientific reports2026
Green and chemical synthesis of PEGylated ginger gold nanoparticles for neuro-nanomedicine applications.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Background Gold nanoparticles (AuNPs) are promising therapeutic-delivery agents for neuro-nanomedicine, but their cytotoxicity from conventional chemical synthesis remains a challenge. Green synthesis using ginger extract offers a safer, neuroprotective alternative. Methods PEGylated AuNPs were prepared through chemical (CS) and green (GS) methods with and without ginger extract. They were analyzed using SEM, TEM, DLS, and zeta potential. Encapsulation efficiency (EE), loading capacity (LC), drug release profile (pH 7.4, 37 °C), and cytotoxicity in PC12 cells (MTT assay, IC₅₀) were measured. Results Spherical nanoparticles (14–19 nm) were confirmed. GS-PEG-Ginger-AuNPs exhibited superior EE (80.7% vs. 61.8%) and LC (90.7% vs. 77.9%) compared to the CS counterpart. The GS formulation also showed a significantly higher cumulative drug release (~ 85% vs. ~60% at 96 h), with release kinetics indicative of anomalous transport (n = 0.52) versus Fickian diffusion (CS, n = 0.45). Critically, GS formulations were highly biocompatible (IC₅₀ > 100 µg/mL; >70–80% cell viability at 100 µg/mL), whereas CS formulations were toxic (IC₅₀ ≈ 68.7–104.4 µg/mL). Conclusion The green-synthesized PEG-Ginger-AuNPs demonstrate enhanced drug loading, sustained release, and exceptional neuronal biocompatibility, underscoring their strong potential as a translatable and safe nanoplatform for clinical neuro-nanomedicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.